News

Raising the bar on data and biosample sharing from AD/ADRD clinical trials

Initiation of AHEAD 3-45 Study

Our Commitment to Equality, Inclusiveness, and Diversity

From the research lab to your doctor’s office – here’s what happens in phase 1, 2, 3 drug trials

Cognition Therapeutics Receives $75.8 Million NIA Grant in Collaboration with the Alzheimer’s Clinical Trials Consortium

First A4 Screening Data

Here’s a way you can help fight Alzheimer’s

Biogen will submit to FDA for approval of Aducanumab – read the Alzforum article with Paul Aisen’s comment